Introduction {#s1}
============

A hallmark of eukaryotic cells is their internal organization by distinct, highly specialized, membrane-enclosed compartments. Vesicular traffic functionally connects these individual compartments while preserving their integrity. The constant vectorial exchange between organelles is ensured by a complex machinery that facilitates the formation of vesicles with selective cargo, vesicle movement, specific tethering of each vesicle at its correct target membrane, and fusion of the vesicle and organelle membranes. Selective tethering and fusion are sequential events, but it remains unclear how tightly they are coupled. Tethering is commonly performed by specific proteins, often in large multi-subunit complexes that bind Rab family GTPases ([@bib47]; [@bib63]). Fusion is mediated by soluble N-ethylmaleimide-sensitive attachment protein receptor (SNARE) proteins ([@bib22]) and Sec1/Munc18 (SM) proteins ([@bib40]).

We study membrane fusion with the vacuoles (lysosomes) of *Saccharomyces cerevisiae* ([@bib57]). The vacuole is a large organelle that continuously undergoes fission and homotypic fusion with other vacuoles. At steady state, wild-type strains of yeast have just a few large vacuoles, but mutations which block vacuole fusion allow unimpeded fission, resulting in cells with numerous small vacuoles. This phenotype allowed the identification of the genes encoding vacuole fusion proteins ([@bib53]). Vacuoles are readily isolable ([@bib1]), and a simple colorimetric assay of their fusion ([@bib15]) permitted definition of the consecutive stages of fusion and the catalysts of each stage ([@bib38]).

Vacuole tethering requires the Rab family GTPase Ypt7p and the heterohexameric Rab effector complex HOPS (homotypic vacuole fusion and protein sorting), which is comprised of Vps11p, Vps16p, Vps18p, Vps33p, Vps39p, and Vps41p ([@bib44]; [@bib58]). Two of these subunits, Vps39p and Vps41p, have direct affinity for Ypt7p, suggesting that one HOPS complex could tether two vacuoles, each bearing Ypt7p ([@bib5]; [@bib37]). Fusion of tethered membranes requires vacuolar SNAREs. Each vacuole has four SNAREs that are required for homotypic fusion: the R-SNARE Nyv1p, the Q~a~-SNARE Vam3p, the Q~b~-SNARE Vti1p, and the Q~c~-SNARE Vam7p ([@bib34]; [@bib52]). Vam7p has the unusual property of lacking a hydrophobic membrane anchor while having an N-terminal membrane targeting domain with affinity for phosphatidylinositol 3-phosphate, HOPS, and acidic lipid ([@bib7]; [@bib27]; [@bib48]; [@bib24]). Vacuolar *cis*-SNARE complexes are disassembled by Sec17p and Sec18p in an ATP-dependent manner, allowing the SNAREs to reassemble into *trans*-complexes, which are essential for fusion ([@bib16]; [@bib30]). HOPS fulfills several functions: Rab-dependent tethering ([@bib17]), catalysis of the assembly of Vam7p into *trans*-SNARE complexes ([@bib65]), and protecting *trans*-SNARE complexes from Sec17p/Sec18p-mediated disassembly ([@bib59]).

The reconstitution of vacuolar fusion in vitro has provided an important complementary approach for examining the individual steps of membrane fusion. In an early study, vacuole detergent extracts were reconstituted into proteoliposomes that could fuse with the purified organelle. Both the SNARE complex and vacuolar Rab GTPase Ypt7p were shown to be essential components of such detergent extracts ([@bib41]). Shortly thereafter, it was demonstrated that proteoliposomes bearing the vacuolar R-SNARE and two fluorescent lipids that exhibit fluorescence quenching, NBD-PE and rhodamine-PE, will interact with non-fluorescent proteoliposomes bearing the three Q-SNAREs to give fluorescence dequenching ([@bib13]). This finding has since been confirmed in several additional studies ([@bib31]; [@bib20]; [@bib14]). A very recent study ([@bib14]) has shown that vacuolar SNAREs are apparently unique among the yeast SNAREs, in that the purified SNAREs of the other yeast organelles will not mediate the dequenching of fluorescent lipids on proteoliposomes without additional proteins or tethering factors. In striking contrast, when fusion was assayed by the mixing of lumenally entrapped proteins while they remain inaccessible to an external competitor ([@bib67]), very little fusion was seen without a tethering agent ([@bib65]). Thus, there are apparently contradictory reports as to whether SNAREs alone can efficiently mediate each stage of the fusion process.

We now report that vacuolar SNAREs alone will only support membrane fusion with an extremely low efficiency. Strikingly, fluorescent lipid dequenching can apparently occur due to *trans*-SNARE interactions that do not necessarily go on to fusion, emphasizing the pivotal importance of content mixing experiments in membrane fusion studies. A tethering/docking step is strictly required for rapid fusion, whether by the main physiological tethering system of Ypt7p and HOPS or by a vacuole-specific tethering mechanism mediated by the interaction of Vam7p\'s PX domain and PI(3)P in *trans.*

Results {#s2}
=======

During biological membrane fusion, the barrier between the cytosol and the contents of the vesicle and target organelles remains intact while the lipids of two apposed bilayers rearrange to form one continuous membrane and the lumenal contents mix. Two principal types of assays have been employed to study this process in reconstituted systems, one based on the mixing of the bilayer lipids, the other based on the mixing of the vesicles\' lumenal contents ([Figure 1A](#fig1){ref-type="fig"}). Lipid dequenching ([Figure 1A](#fig1){ref-type="fig"}, part 1) has been the most commonly used assay for membrane fusion. In this assay ([@bib49]), one set of proteoliposomes bears two fluorescent lipids while the other has none. The two fluorophores are subject to fluorescence resonance energy transfer (FRET), so that the fluorescence emission of the 'donor' fluorophore is quenched due to its close proximity to the 'acceptor' fluorophore. FRET efficiency varies with the 6th power of the average distance between fluorophores ([@bib10]); thus, fusion to unlabeled proteoliposomes, causing a twofold dilution of fluorescent lipids and thereby an increased average distance between fluorophores, results in a remarkable loss of quenching, and the ensuing increase in donor fluorescence is taken as a measure of fusion. In a modified version of this assay, donor and acceptor fluorophores start out on separate proteoliposome populations, and are brought into close contact when apposed bilayers fuse and their lipids mix ([Figure 1A](#fig1){ref-type="fig"}, part 2). The surrogate for fusion in this case is the decrease in fluorescence intensity of the donor fluorophore (due to quenching by the acceptor fluorophore via FRET). The quenching assay primarily reports the initial round of events, while the signal for the dequenching assay keeps increasing with consecutive rounds ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). However, hemifusion (a possible intermediate in which only the outer leaflets of apposed bilayers join) and lysis (disruption of the lipid bilayer with a loss of lumenal integrity) and ensuing re-annealing of bilayer fragments could also lead to lipid mixing which would be detected by these assays. Therefore, alternative assays that measure the mixing of lumenal contents in the continuous presence of an external competitor ([Figure 1A](#fig1){ref-type="fig"}, part 3), a strategy that has commonly been used to study the fusion of isolated organelles, are important as well.10.7554/eLife.03251.003Figure 1.Comparison of lipid mixing and content mixing assays.(**A**) Assays used to study membrane fusion in vitro and possible outcomes. (**B**) Description of proteoliposomes as used in the following figures. (**C**--**E**) Two populations of 4SNARE-RPLs (with 1.5 mol% Marina-Blue-phosphatidylethanolamine \[PE\] and NBD-PE containing biotinylated R-phycoerythrin, or with no fluorescent lipids containing Cy5-labeled streptavidin; 250 µM lipid each) were incubated at 27°C with combinations of Sec17p, Sec18p, and HOPS, and assayed for 10 min for: lipid dequenching (**C**), lumenal content mixing protected from 5 µM external streptavidin (**D**), and mixing of lumenal content markers in the absence of external streptavidin, thus measuring both fusion and lysis (**E**). (**F**--**H**) Incubations were as in (**C**--**E**), but with RPLs bearing either the R-SNARE Nyv1p or the 3Q-SNAREs Vam3p, Vti1p, and Vam7p. Final concentrations of proteins were: Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM). The mean and standard deviations of three experiments are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.003](10.7554/eLife.03251.003)10.7554/eLife.03251.004Figure 1---figure supplement 1.Representative kinetic data for panels C--H in [figure 1](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.004](10.7554/eLife.03251.004)10.7554/eLife.03251.005Figure 1---figure supplement 2.Sensitivity of lipid dequenching and lipid quenching assays to simulated rounds of fusion.(**A**) Mixed micellar solutions of DLPC and β-octylglucoside, containing the fluorescently labeled lipids Marina-Blue-phosphatidylethanolamine (PE) (0.2 mol%) and NBD-PE (1.5 mol%), were mixed with unlabeled mixed micellar solutions prior to liposome formation. To simulate 0, 1, 2, 3, 4, or 5 rounds of fusion, 1 part of labeled lipid solution was mixed with 0, 1, 2, 3, 4, or 5 parts of unlabeled lipid solution. After liposome formation by dialysis, the fluorescence intensity of these liposomes (250 µM lipid) was determined in the presence or absence of detergent (0.1% \[wt/vol\] Thesit). The intensity measured in the absence of detergent is expressed as percentage of the signal intensity measured in the presence of detergent. (**B**) As described in (**A**), but 1 part of Marina-Blue-PE (0.2 mol%) mixed micellar solution was mixed with 0--5 parts of NBD-PE (3 mol%) mixed micellar solution prior to liposome formation.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.005](10.7554/eLife.03251.005)

We employ a reconstituted fusion assay ([@bib67]) that allows us to measure both lipid and content mixing simultaneously. Proteoliposomes ([Figure 1B](#fig1){ref-type="fig"}) are prepared by dialysis of mixed micellar solutions of detergent, lipids which mimic the reported vacuolar composition ([@bib66]; [@bib42]), two reporter fluorescent lipids (Marina-Blue-phosphatidylethanolamine (MB-PE) and/or NBD-PE), and pure recombinant proteins: the four vacuolar SNAREs, the prenylated Rab Ypt7p, and either of two lumenal markers (streptavidin derivatized with the fluorophore Cy5 \[Sa-Cy5\] or biotinylated R-phycoerythrin \[PhycoE\]). These proteoliposomes are mixed and incubated with HOPS, Sec17p, Sec18p, Mg^2+^:ATP, and non-fluorescent streptavidin (to block any extra-lumenal association between biotinylated phycoerythrin and Cy5-streptavidin that might have been released by lysis). To measure both fusion and lysis, assays were also performed without added non-fluorescent streptavidin. In assays in which proteoliposomes bear each of the four SNAREs, as on the organelle itself, dequenching of the lipidic fluorophores ([Figure 1C](#fig1){ref-type="fig"}), lumenal compartment mixing which is continuously protected from external streptavidin ([Figure 1D](#fig1){ref-type="fig"}), and content mixing plus lysis ([Figure 1E](#fig1){ref-type="fig"}) required HOPS, Sec17p, and Sec18p (for this and subsequent figures, the extent of fusion after 10 min was used to estimate fusion activity; representative examples of kinetic data are shown as figure supplements).

Previous studies of organelle fusion ([@bib51]), or dequenching experiments with proteoliposomes bearing SNARE combinations ([@bib13]; [@bib31]), have suggested that *trans*-SNARE complexes form between three Q-SNAREs anchored to one membrane and an R-SNARE (Nyv1p) anchored to the apposed membrane. Such an arrangement has allowed the study of sub-reactions with reduced complexity. We therefore prepared proteoliposomes as before ([Figure 1B](#fig1){ref-type="fig"}), but instead of bearing all four SNAREs, one fusion partner had only the R-SNARE Nyv1p and the other bore the 3Q-SNAREs. Surprisingly, these proteoliposomes showed very limited protected lumenal compartment mixing in the absence of other proteins ([Figure 1G](#fig1){ref-type="fig"}, column 1), although even this very limited fusion was blocked by Sec17p/Sec18p (column 5) and thus likely required direct *trans*-SNARE interaction. Substantial fusion only occurred in the presence of HOPS and, as noted before ([@bib31]), was further enhanced by Sec17p/Sec18p in addition to HOPS (columns 4 and 8). In contrast to the dependence of content mixing on HOPS, there was substantial lipid dequenching without the addition of HOPS ([Figure 1F](#fig1){ref-type="fig"}, column 1), as reported ([@bib31]). To address this discrepancy, we turned to a more detailed analysis of the lipid dequenching assay.

Lipid dequenching {#s2-1}
-----------------

Does the dequenching assay actually measure symmetric lipid mixing between the two proteoliposome populations? Proteoliposomes were prepared with both MB-PE and NBD-PE on the R-SNARE proteoliposomes or on the 3Q-SNARE proteoliposomes. Strikingly, the dequenching signal was seen when the fluorescent lipids were both on the R-SNARE proteoliposomes, but not when they were on the 3Q-SNARE proteoliposomes ([Figure 2A](#fig2){ref-type="fig"}, dark gray bars). For these direct comparisons of dequenching when the fluorophores are on one or the other proteoliposome, the proteoliposomes were mixed at a 1:1 ratio ([Figure 2A](#fig2){ref-type="fig"}). As in most reported dequenching assays, increasing the proportion of non-fluorescent acceptor 3Q-SNARE proteoliposomes enhances the signal such that up to 60% of maximal dequenching is achieved in 10 min ([Figure 2B](#fig2){ref-type="fig"}, light gray columns), whereas little dequenching of fluorescent 3Q-SNARE proteoliposomes is seen when incubated with even a 16-fold excess of non-fluorescent 1R-proteoliposomes ([Figure 2B](#fig2){ref-type="fig"}, dark gray columns). Providing an excess of 3Q-RPLs, but not 1R-RPLs, also promoted content mixing (see [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) beyond what was seen at a 1:1 ratio of both RPLs, suggesting that only a fraction of the 3Q-RPLs are fusion competent. Dequenching does require *trans*-SNARE interactions: it is blocked by antibody to Vam3p, by recombinant soluble domain of Nyv1p, or by Sec17p/Sec18p ([Figure 2C](#fig2){ref-type="fig"}, light gray columns), which are reported ([@bib59]) to disassemble *trans*-SNARE complexes. Each of the 14 compositions of SNAREs other than 3Q on the acceptor, non-fluorescent proteoliposomes did not support dequenching ([Figure 2C](#fig2){ref-type="fig"}, the average and standard deviation of these is shown for simplicity as a dark gray column). Thus, proteoliposomes can undergo *trans*-SNARE interactions that lead to asymmetric lipid dequenching without symmetrical lipid mixing or proportionate fusion.10.7554/eLife.03251.006Figure 2.Asymmetric lipid dequenching.(**A**) Lipid dequenching reactions of 1R- and 3Q-RPLs (250 µM lipid each), with both fluorescent lipids (Marina-Blue-phosphatidylethanolamine \[MB-PE\] and NBD-PE, 1.5 mol% each) on either the 1R-RPLs or the 3Q-RPLs. Incubations contained either Sec17p (600 nM) and Sec18p (200 nM) (light gray) or no additional proteins (dark gray). (**B**) Lipid dequenching reactions of MB/NBD-labeled 1R- (light gray) or 3Q-RPLs (dark gray) with increasing amounts of non-labeled complementary RPLs (3Q or 1R; 1:1 corresponds to 50 µM lipid of each). No additional proteins were added. (**C**) Sensitivity of lipid dequenching reactions of 1R(MB/NBD)-RPLs and 3Q-RPLs to various inhibitors that might prevent *trans*-SNARE complex formation. Incubations received: (1) no addition, (2) Sec17p/Sec18p (400 nM each), (3) antibodies directed against Vam3p (1 µM), or (4) soluble Nyv1p(1-231) (1 µM). Column 5: 1R(MB/NBD)-RPLs were incubated with non-fluorescent RPLs bearing various combinations of SNAREs other than 3Q: Q~abc~R, Q~bc~R, Q~ac~R, Q~ab~R, Q~c~R, Q~b~R, Q~bc~, Q~a~R, Q~ac~, Q~ab~, R, Q~c~, Q~b~, Q~a~. The extent of these reactions was comparably low for all conditions, and is shown as average for these 14 conditions with standard deviations.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.006](10.7554/eLife.03251.006)10.7554/eLife.03251.007Figure 2---figure supplement 1.Representative kinetic data for panels A--C in [figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.007](10.7554/eLife.03251.007)

Does the presence of the lipidic probes on the R-SNARE or 3Q-SNARE proteoliposomes affect the actual fusion reaction, as measured by protected lumenal content mixing? The asymmetry of lipid dequenching, controlled by the distribution of the probes ([Figure 3A](#fig3){ref-type="fig"}), is not reflected in asymmetry of fusion per se in the very same incubations ([Figure 3B](#fig3){ref-type="fig"}). Even lipid quenching assays, in which MB-PE and NBD-PE are initially incorporated separately into R-SNARE or 3Q-SNARE proteoliposomes, show an asymmetry in quenching ([Figure 3C](#fig3){ref-type="fig"}) that is not reflected in fusion per se ([Figure 3D](#fig3){ref-type="fig"}). This asymmetry could not be attributed to differences in RPL size ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), or fluorophore or protein incorporation ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}).10.7554/eLife.03251.008Figure 3.Discrepancies between lipid mixing and content mixing assays in 1R-3Q RPL fusion reactions.Incubations contained Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM), as indicated. (**A** and **B**) Incubations contained 1R-RPLs (containing Biotin-PhycoE) and 3Q-RPLs (containing Streptavidin-Cy5) (250 µM lipid each), with the two fluorescent lipids Marina-Blue-phosphatidylethanolamine (MB-PE) and NBD-PE (1.5 mol% each) being together on either the 1R-RPLs or the 3Q-RPLs. Lipid dequenching (**A**) and protected lumenal content mixing (**B**) were recorded from the same reactions. (**C** and **D**) Incubations bore 1R-RPLs (containing Biotin-PhycoE) and 3Q-RPLs (containing Streptavidin-Cy5) (250 µM lipid each), with each RPL bearing a single fluorescent lipid, either Marina-Blue-phosphatidylethanolamine (MB-PE) (1 mol%) or NBD-PE (3 mol%). Lipid quenching (**C**) and protected lumenal content mixing (**D**) were recorded from the same reactions.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.008](10.7554/eLife.03251.008)10.7554/eLife.03251.009Figure 3---figure supplement 1.Representative kinetic data for panels A--D in [figure 3](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.009](10.7554/eLife.03251.009)10.7554/eLife.03251.010Figure 3---figure supplement 2.Characterization of liposome size by dynamic light scattering.(**A**--**H**) The size distribution of various proteoliposome preparations was analyzed by dynamic light scattering with a Zetasizer nano ZS (Malvern Instruments, Westborough, MA) through non-invasive back-scatter at 173°. Samples of 400 μl at a lipid concentration of 20 μM were measured in low volume disposable sizing cuvettes at 25°C. The Z averages (r.nm) were: 101.5 for 1R(MB/NBD) (**A**), 90.63 for 1R() (**B**), 99.18 for 1R(MB) (**C**), 91.07 for 1R(NBD) (**D**), 89.78 for 3Q() (**E**), 95.36 for 3Q(MB/NBD) (**F**), 86.93 for 3Q(NBD) (**G**), and 89.40 for 3Q(MB) (**H**).**DOI:** [http://dx.doi.org/10.7554/eLife.03251.010](10.7554/eLife.03251.010)10.7554/eLife.03251.011Figure 3---figure supplement 3.Characterization of dye and protein incorporation.(**A**) Samples (20 µl) of 1R(MB/NBD) and 3Q(MB/NBD) RPLs (25 µM lipid) were incubated for 30 min at 27°C in the presence or absence of Thesit (0.2% \[wt/vol\]) in 384-well plates in a SpectraMax Gemini XPS, and the fluorescence of Marina-Blue (Ex: 370 nm, Em: 465 nm, cutoff: 420 nm) and NBD (Ex: 460 nm, Em: 538 nm, cutoff: 515 nm) was recorded. The average of three repeats ± standard deviations is shown. (**B**) RPLs of various composition were analyzed for their protein composition by SDS-PAGE and Colloidal Coomassie staining.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.011](10.7554/eLife.03251.011)

Might dequenching that does not seem to represent fusion reflect a peculiar physical property of one or the other fluorophore? 3Q- and 1R-proteoliposomes were prepared with three sets of fluorescent PE probes, either MB and NBD, NBD and rhodamine, or Oregon-Green and Texas-Red. In the absence of HOPS or Sec17p/Sec18p, the same asymmetric dequenching signal was seen in each case ([Figure 4A--C](#fig4){ref-type="fig"}, no addition). We do not know how *trans*-SNARE interactions lead to this dequenching, but it is not symmetric, as expected for true lipid mixing, and is not proportionate to the content mixing for each reaction condition; thus, it cannot be relied on as a faithful reporter of fusion.10.7554/eLife.03251.012Figure 4.Asymmetric lipid dequenching is seen with different pairs of fluorescent lipidic markers.(**A**--**C**) Lipid dequenching reactions of 1R- and 3Q-RPLs (250 µM lipid each) had combinations of Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM), as indicated. Either the 1R-RPLs (light gray) or the 3Q-RPLs (dark gray) bore pairs of fluorescently labeled lipids (1.5 mol% each): Marina-Blue (MB) and NBD (**A**), NBD and rhodamine (Rh) (**B**), or Oregon-Green (OG) and Texas-Red (TR) (**C**).**DOI:** [http://dx.doi.org/10.7554/eLife.03251.012](10.7554/eLife.03251.012)10.7554/eLife.03251.013Figure 4---figure supplement 1.Representative kinetic data for panels A--C in [figure 4](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.013](10.7554/eLife.03251.013)

A tethering requirement {#s2-2}
-----------------------

While there was far less protected lumenal content mixing between 3Q- and 1R-SNARE proteoliposomes in the absence of HOPS, Sec17p, and Sec18p than in their presence ([Figure 1G](#fig1){ref-type="fig"}, columns 1 vs 8), even this low level (column 1) was suppressed by Sec17p/Sec18p (column 5) and thus presumably relied on the SNAREs. Was this fusion independent of tethering, that is, did it rely on direct formation of stable proteoliposome adherence through 4-SNARE coiled-coil domain assembly, or did another kind of interaction mediate tethering? The Vam7p N-terminal PX domain has direct affinity for PI(3)P ([@bib7]), which is important for fusion ([@bib12]). 3Q- and 1R-proteoliposomes were prepared with or without PI(3)P. They were incubated in each combination without further protein addition, with HOPS, with Sec17p/Sec18p, or with HOPS/Sec17p/Sec18p, and their protected lumenal compartment mixing was assayed ([Figure 5A](#fig5){ref-type="fig"}). Strikingly, with PI(3)P only on the R-SNARE proteoliposomes, fusion was as vigorous without HOPS as in its presence ([Figure 5](#fig5){ref-type="fig"}, columns 5 and 7). This fusion was blocked by Sec17p/Sec18p (column 6) and was not seen when the PI(3)P was entirely absent (column 1) or when PI(3)P was only on the 3Q-SNARE proteoliposomes (column 9). The content mixing that was seen when PI(3)P was on the R-SNARE proteoliposomes alone was strongly suppressed when PI(3)P was present on the 3Q-RPLs as well (columns 5 vs 13), presumably because the PX domain is engaged in an interaction with PI(3)P in *cis,* rendering a *trans* interaction less likely. The delay in reaction kinetics for conditions with Sec17, Sec18, and HOPS and no PI(3)P on the 3Q-RPLs ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}, purple lines) probably reflects the requirement for phosphoinositides for the synergy between Sec17/Sec18 and HOPS ([@bib32]). The fusion that is supported by the presence of PI(3)P on the R-SNARE proteoliposomes can be ascribed to its binding in *trans* by the PX domain of Vam7p, as 3Q-SNARE proteoliposomes which were made with Vam7pΔPX will not fuse with R-SNARE proteoliposomes which bear PI(3)P (column 17). After 10 min assays, the very low lumenal compartment mixing values observed with the RPLs alone were not significantly above those seen with inhibition by Sec17p and Sec18p ([Figure 5A](#fig5){ref-type="fig"}, lower panel, columns 1 and 2). To determine whether SNARE-bearing RPLs alone can undergo any full fusion at all on their own, we performed an extended fusion assay with 3Q- and 1R-proteoliposomes without PI(3)P in the presence or absence of added HOPS ([Figure 5B](#fig5){ref-type="fig"}). Detectable fusion could in fact be supported by SNAREs alone (blue), albeit at less than a 100th the rate as seen in the presence of HOPS (red).10.7554/eLife.03251.014Figure 5.Modulation of fusion activity through asymmetric distribution of PI(3)P.(**A**) 1R-RPLs (with 0.5 mol% Marina-Blue-phosphatidylethanolamine \[PE\], containing biotinylated R-phycoerythrin) and 3Q-RPLs (with 3 mol% NBD-PE, containing Cy5-labeled streptavidin), bearing PI(3)P as indicated, were assayed for protected lumenal compartment mixing. Where indicated (columns 17--20), 3Q-RPLs bore a truncated version of the Qc-SNARE Vam7p that lacks the PI(3)P binding PX domain ([@bib61]). Reactions contained Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM), as indicated. The lower panel provides a magnified view of the bottom 5% of the data (indicated by dotted box). (**B**) Kinetics of 1R-3Q content mixing assays with RPLs not bearing PI(3)P. Reactions contained HOPS (100 nM; red curve), Sec17p and Sec18p (600 and 200 nM; gray curve), or no added proteins (blue curve). The averages of five experiments are shown. The reactions containing Sec17p/Sec18p were normalized to zero, and these values were subtracted from all other conditions. Light-colored areas indicate standard deviations.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.014](10.7554/eLife.03251.014)10.7554/eLife.03251.015Figure 5---figure supplement 1.Representative kinetic data for panel A in [figure 5](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.015](10.7554/eLife.03251.015)10.7554/eLife.03251.016Figure 5---figure supplement 2.Effect of varying the ratio of 1R to 3Q RPLs.Protected lumenal compartment mixing was measured as the decrease in fluorescence intensity of Biotin-PhycoE when it binds to Streptavidin-Cy5. Incubations either contained Sec17p (600 nM) and Sec18p (200 nM) (light gray) or no additional proteins (dark gray). All 1R-RPLs contained PI(3)P (1 mol%), while all 3Q-RPLs did not. (**A**) Content mixing reactions of 1R-RPLs (50 µM lipid; containing the lumenal marker Biotin-PhycoE) and 3Q-RPLs (0, 50, 150, or 450 µM lipid; containing the lumenal marker Streptavidin-Cy5). (**B**) Content mixing reactions of 3Q-RPLs (50 µM lipid; containing the lumenal marker Biotin-PhycoE) and 1R-RPLs (0, 50, 150, or 450 µM lipid; containing the lumenal marker Streptavidin-Cy5).**DOI:** [http://dx.doi.org/10.7554/eLife.03251.016](10.7554/eLife.03251.016)

Fusion and *trans*-association of SNAREs {#s2-3}
----------------------------------------

Does this dramatic difference in fusion rates reflect a proportionate inability of the three Q-SNAREs on proteoliposomes to engage with R-SNAREs in the absence of a tether? To study how much *trans*-interaction occurs between membrane-bound 3Q-SNAREs and membrane-bound R-SNAREs in the presence or absence of HOPS, we performed a content mixing reaction ([Figure 6A](#fig6){ref-type="fig"}) and also subjected samples which had been detergent-solubilized to immunoprecipitation with anti-Vam3p antibodies to determine the amount of Nyv1p that co-precipitated as a measure of *trans*-SNARE interaction ([Figure 6B](#fig6){ref-type="fig"}). The detergent bore a large excess of GST-Nyv1p, sufficient to suppress any association between the 3Q-SNAREs and wild-type Nyv1p after detergent-solubilization ([Figure 6](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The presence of HOPS led to an increase in the *trans*-association of membrane anchored SNAREs ([Figure 6B](#fig6){ref-type="fig"}, compare lanes 3 and 4). However, this increase was less than fourfold, and thus insufficient to explain the difference in content mixing rates ([Figure 6A](#fig6){ref-type="fig"}). Quantitation of replicate experiments ([Figure 6C](#fig6){ref-type="fig"}) shows that about one third as much *trans*-SNARE complex formed in the absence of HOPS (column 3) as in its presence (column 4), whereas fusion was over 100 times faster in the presence of HOPS (columns 1, 2). Might this reflect an inability of the 3Q-SNAREs to interact with Nyv1p without HOPS? When incubations bore the recombinant soluble domain of Nyv1p at the same 100 nM concentration as was otherwise present on RPLs in our assay, the soluble Nyv1p readily bound to the Q-SNAREs regardless of the presence or absence of HOPS ([Figure 6B](#fig6){ref-type="fig"}, compare lanes 7 and 8). Furthermore, 100 nM soluble Nyv1p can suppress most of the content mixing reaction ([Figure 6D](#fig6){ref-type="fig"}), just as fusion was blocked by the mixed soluble domains of the three Q-SNAREs ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}), and inhibition by added soluble domain of Nyv1p was reversible by including the SNARE complex disassembly chaperones Sec17/Sec18 ([Figure 6E](#fig6){ref-type="fig"}). This indicates that the 3Q-SNARE complexes were capable of engaging in complex formation with membrane-bound R-SNAREs, but in a manner that did not lead to fusion. To test whether the highly disproportional increase in *trans*-SNARE association and content mixing can be attributed to a possible requirement for high cooperativity of SNARE complexes, we examined the levels of content mixing and *trans*-SNARE interactions when R-RPLs were used that had been reconstituted with lower amounts of Nyv1p ([Figure 7](#fig7){ref-type="fig"}). Lower levels of Nyv1p did not lead to a drastic diminution of fusion activity ([Figure 7A,C](#fig7){ref-type="fig"}), but resulted in lower amounts of *trans*-SNARE association ([Figure 7B,D](#fig7){ref-type="fig"}). Since the amount of *trans*-SNARE interaction that was detected at low Nyv1p levels with HOPS was lower than the amount seen with high Nyv1p levels without HOPS ([Figure 7B,D](#fig7){ref-type="fig"}, lane 2 vs lane 7), yet the amount of fusion was drastically higher in the sample containing HOPS ([Figure 7A,C](#fig7){ref-type="fig"}, lane 2 vs lane 7), the requirement for high cooperativity can be ruled out as an explanation for the observed discrepancy between increases in *trans*-SNARE interaction and fusion.10.7554/eLife.03251.017Figure 6.HOPS increases the rate of content mixing substantially more than the formation of *trans*-SNARE associations.(**A**) Kinetics of 1R-3Q content mixing assays. RPLs (reconstituted with a protein:lipid ratio of 1:2500 for SNAREs) were incubated for 30 min at 27°C before and after the addition of HOPS (100 nM) or its buffer. (**B**) Additional 40 µl reactions that were performed in parallel were analyzed for *trans*-SNARE association by co-immunoprecipitation of Nyv1p (R-SNARE) with Vam3p (Q~a~-SNARE). Lanes 3 and 4 correspond to the conditions as shown in (**A**). Lanes 7 and 8 are from equivalent reactions, but containing soluble Nyv1p instead of R-RPLs. For lanes 1, 2, 5, and 6, the components were mixed directly in detergent solution without prior incubation. (**C**) Quantification of content mixing and *trans*-SNARE association (as seen in panels **A** and **B**) from three independent repeat experiments. The rate of fusion was determined as the slope for the first minute of the content mixing reaction after addition of HOPS or its buffer (between minutes 30 and 31). *Trans*-SNARE interactions were quantified as the amount of Nyv1p that co-precipitated with Vam3p (lanes 3 and 4 in panel **B**) using UN-SCAN-IT gel 5.3 software (Silk Scientific, Orem, UT). (**D**) 1R- and 3Q-RPLs were mixed with increasing concentrations of soluble Nyv1p (sR), and incubated for 30 min at 27°C. HOPS (100 nM) was added, and the reactions were assayed for protected lumenal compartment mixing. (**E**) A mixture of 1R- and 3Q-RPLs was pre-incubated with or without 1 µM soluble Nyv1p for 30 min at 27°C. Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM) or their respective buffers were added as indicated, and the reactions were assayed for protected lumenal compartment mixing.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.017](10.7554/eLife.03251.017)10.7554/eLife.03251.018Figure 6---figure supplement 1.Suppression of the formation of 1R-3Q SNARE complexes in detergent by increasing concentrations of GST-tagged Nyv1p.The 40 µl fusion reactions were incubated at 27°C as indicated, and analyzed for *trans*-SNARE association by co-immunoprecipitation of Nyv1p (R-SNARE) with Vam3p (Q~a~-SNARE). The co-immunoprecipitation was carried out in the presence of increasing concentrations of GST-Nyv1p. Lanes 1 and 2 contained only R- or 3Q-RPLs. Lanes 3-6 contained R- and 3Q-RPLs. Lanes 7 and 8 contained 3Q-RPLs and soluble Nyv1p.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.018](10.7554/eLife.03251.018)10.7554/eLife.03251.019Figure 6---figure supplement 2.Representative kinetic data for panels D--E in [figure 6](#fig6){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.019](10.7554/eLife.03251.019)10.7554/eLife.03251.020Figure 6---figure supplement 3.Reversible inhibition by soluble Q-SNAREs.(**A**) 1R- and 3Q-RPLs were mixed with increasing concentrations of soluble Vam3p, Vti1p, and Vam7p, and incubated for 30 min at 27°C. HOPS (100 nM) was added, and the reactions were assayed for protected lumenal compartment mixing. (**B**) A mixture of 1R- and 3Q-RPLs was pre-incubated with or without 4 µM soluble Vam3p, Vti1p, and Vam7p for 30 min at 27°C. Sec17p (600 nM), Sec18p (200 nM), and HOPS (100 nM) or their respective buffers were added as indicated, and the reactions were assayed for protected lumenal compartment mixing. (**C**) Reactions as in (**A**), but with increasing concentrations of either soluble Vam3p, or soluble Vti1p, or Vam7p individually.**DOI:** [http://dx.doi.org/10.7554/eLife.03251.020](10.7554/eLife.03251.020)10.7554/eLife.03251.021Figure 7.High cooperativity does not explain the disproportion between *trans*-SNARE interaction and fusion rate resulting from HOPS addition.(**A**) Kinetics of content mixing reactions of 3Q-RPLs (reconstituted with a protein:lipid ratio of 1:2000 for Vam3p, Vti1p, and Vam7p) and 1R-RPLs (reconstituted with a protein:lipid ratio of either 1:2000 \[blue\], 1:4000 \[red\], 1:8000 \[green\], or 1:16,000 \[purple\] for Nyv1p). RPLs were incubated for 30 min at 27°C before and HOPS (100 nM) or its buffer were then added. (**B**) Equivalent 40 µl reactions were analyzed for *trans*-SNARE association by co-immunoprecipitation of Nyv1p (R-SNARE) with Vam3p (Q~a~-SNARE). Lanes 1--8 correspond to the conditions as shown in (**A**) with odd numbers representing conditions with no addition and even numbers representing conditions with HOPS (100 nM). For lanes a, b, c, and d, the components were mixed directly in detergent solution without prior incubation. (**C**) Quantification of content mixing (as seen in panel **A**) from three independent repeat experiments. The rate of fusion was determined as the slope for the first 10 min of the content mixing reaction (between minutes 0 and 10) for samples that did not receive HOPS or as the slope for the first minute of the content mixing reaction after addition of HOPS (between minutes 30 and 31). (**D**) Quantification of *trans*-SNARE association (as seen in panel **B**). *Trans*-SNARE interactions were quantified as the amount of Nyv1p that co-precipitated with Vam3p (lanes 1--8 in panel **B**) using UN-SCAN-IT gel 5.3 software (Silk Scientific, Orem, UT), and are represented as percentage of the amount of Nyv1p that co-precipitated in the reaction that contained HOPS and R-RPLs with a SNARE:lipid ratio of 1:2000 (lane 8 in panel **B**).**DOI:** [http://dx.doi.org/10.7554/eLife.03251.021](10.7554/eLife.03251.021)

Discussion {#s3}
==========

Our knowledge of the initial steps of membrane fusion is limited, and the terminology to describe these processes is vague. 'Tethering' often refers to *trans*-interactions of membranes that are of low affinity, reversible, or do not involve SNAREs, and 'docking' is reached when *trans*-SNARE complexes have formed. These terms are used loosely, even interchangeably, and it has remained unclear whether and how the functions of Rab GTPases, their effectors, SM proteins, and SNAREs are coupled or even related. The steps that lead to *trans*-SNARE complex formation are dynamic and interwoven, and we are only beginning to understand how they lead to membrane fusion.

Several biochemical assays have been developed to monitor the fusion process in vitro. Most studies with isolated organelles have assayed fusion as the mixing of lumenal contents. Studies with reconstituted proteoliposomes, in contrast, have relied heavily on lipid dequenching assays to infer the merging of two lipid bilayers. Discrepancies of lipid mixing and content mixing have repeatedly been noted in the past: for example, neuronal SNAREs alone do not produce much content mixing yet readily promote lipid dequenching ([@bib25]; [@bib8]), content mixing occurs seconds after initial lipid mixing in influenza virus-induced fusion ([@bib9]), and content mixing occurs with a delay of several minutes after lipid mixing in vacuolar fusion ([@bib23]).

We have recently described an assay that allows concurrent measurement of both lipid and content mixing ([@bib67]). We have reconstituted a fusion reaction that mimics the homotypic fusion of yeast vacuoles, that is, with the four SNAREs in a *cis*-complex on both membranes, depending on Sec17p/Sec18p for ATP-dependent priming and Ypt7p:HOPS for tethering (see [@bib57] for review). Both content and lipid mixing assays show that this reaction requires Sec17p, Sec18p, and HOPS ([Figure 1C,D](#fig1){ref-type="fig"}). A modified reaction scheme, in which one population of RPLs bears the R-SNARE Nyv1p, while the other population bears the three Q-SNAREs Vam3p, Vti1p, and Vam7p, allows study of a sub-reaction that bypasses the need for Sec17p/Sec18p mediated priming. This condition has repeatedly been reported to allow lipid mixing to occur without the need for any additional components ([@bib13]; [@bib31]). While we could reproduce this finding ([Figure 1F](#fig1){ref-type="fig"}, column 1), we observed a substantially lower amount of content mixing for the same condition ([Figure 1G](#fig1){ref-type="fig"}, column 1). Furthermore, among the several sets of SNAREs of yeast organelles, only the vacuolar SNAREs showed a purported fusion signal ([@bib20]; [@bib14]). Lipid mixing without proportional content mixing may indicate hemifusion (see [Figure 1A](#fig1){ref-type="fig"}). However, the lipid dequenching signal showed an asymmetric character, depending on the two fluorescent lipids being present on the R-SNARE-bearing RPLs ([Figure 2A,B](#fig2){ref-type="fig"}). It is nevertheless possible to suppress this signal with well-established inhibitors of fusion that interfere with the formation of *trans*-SNARE complexes ([Figure 2C](#fig2){ref-type="fig"}). The fluorescent lipids did not appear to modulate the capacity of RPLs to fuse, as content mixing was not affected by the presence or distribution of fluorescent lipids ([Figure 3](#fig3){ref-type="fig"}). The effect was also not limited to a specific set of fluorescent lipids ([Figure 4](#fig4){ref-type="fig"}). We cannot explain this asymmetric behavior, but it may be related to an undefined interaction between vacuolar SNAREs and the fluorescent lipids. The latter might be selectively transferred to another membrane that contains a particular SNARE via an interaction with that SNARE; transfer of lipid dyes between membranes has been reported for rhodamine B lipids ([@bib35]). Basic residues in the juxtamembrane regions of a Q-SNARE might facilitate transfer of the fluorescent lipids from the R-RPLs when the two membranes are brought into proximity by *trans*-SNARE complex assembly, thus catalyzing transfer from the R- to the 3Q-RPLs. In any case, the lipid mixing assay needs to be employed with great caution, and should ideally only serve as a complement to content mixing experiments. Lipid dequenching has provided many valuable lessons, but can apparently report events other than true fusion.

A vigorous content mixing signal, which is always accompanied by a lipid mixing signal (dequenching or quenching), is only seen in the presence of HOPS ([Figure 3](#fig3){ref-type="fig"}), indicating that tethering is a vital component of the fusion process. The small amount of content mixing in 1R-3Q reactions that was seen without added protein was suppressed by the addition of Sec17p/Sec18p ([Figure 1G](#fig1){ref-type="fig"}, compare columns 1 and 5), indicating that it did indeed represent SNARE-dependent true membrane fusion. A previous report has shown that the *trans*-interaction of PI(3)P and the PX domain of the Qc-SNARE Vam7p could promote tethering ([@bib60]). This interaction was partially responsible for the SNARE-dependent content mixing seen without additional proteins, since the complete absence of PI(3)P, its asymmetric disposition on 3Q-RPLs, or a truncated form of Vam7p lacking its PX domain further reduced the small amount of content mixing seen without HOPS ([Figure 5A](#fig5){ref-type="fig"}). In contrast, when PI(3)P was only present on R-SNARE RPLs, rapid fusion did not require HOPS ([Figure 5A](#fig5){ref-type="fig"}, columns 5 and 6), establishing a condition with reduced complexity in which an SM function is not absolutely required. It remains to be determined whether the Vam7p:PI(3)P tethering plays any role on intact vacuoles, where priming releases Vam7p early in the fusion reaction ([@bib2]), or if it is merely a phenomenon seen in in vitro reconstitutions with purified components. In this context, we note that the content mixing supported by Vam7p:PI(3)P tethering is fully suppressed in the presence of Sec17p/Sec18p ([Figure 5A](#fig5){ref-type="fig"}, column 6). The ubiquitous presence of Sec17p/Sec18p in the cell may underlie a strict requirement for HOPS and other large tethering complexes in vivo. HOPS has the capacity to recruit Vam7p ([@bib65]), to proofread *trans*-SNARE complexes ([@bib46]), and to protect them from disassembly by Sec17p/Sec18p ([@bib17]; [@bib59]).

While the requirement for a tether was not absolute, the addition of HOPS stimulated the rate of the reaction more than 100-fold ([Figure 5B](#fig5){ref-type="fig"}, [Figure 6C](#fig6){ref-type="fig"}). Colliding SNARE-bearing membranes form spontaneous *trans*-SNARE complexes ([Figure 6D](#fig6){ref-type="fig"}, lane 3). These can occasionally trigger fusion, but the rate achieved under such a condition is of questionable physiological relevance. This uncertainty is reinforced by the fact that mutations in Rab GTPases or tethering complexes have as strong a phenotype as mutations in SNARE proteins ([@bib53]). The addition of HOPS stimulates the fusion reaction more than 100-fold, yet it only increases the amount of *trans*-SNARE interaction a few-fold ([Figure 6C,D](#fig6){ref-type="fig"}). This shows that the role of HOPS and tethering goes beyond merely facilitating *trans*-SNARE complex formation. The *trans*-SNARE complexes that form spontaneously are very inefficient in catalyzing membrane fusion. This indicates that it is not just a matter of quantity, but that additional factors are important to produce *trans*-SNARE interaction of the right quality to facilitate membrane fusion. Fusion-incompetent SNARE complexes have been observed in other systems (reviewed in [@bib6]; [@bib40]), and it will be crucial to determine what differentiates a productive from a non-productive complex, and what aids the formation of one over the other. Our findings do not vitiate the central role of *trans*-SNARE complexes in fusion; rather, they reveal that a distinct tethering step is a critical upstream event that substantially increases the rate of SNARE-mediated fusion, as suggested ([@bib45]), and its mode of action is not limited to increasing the quantity of *trans*-SNARE pairings.

Reconstitution studies using lipid dequenching assays and endosomal SNAREs have also suggested that SNAREs alone suffice to drive fusion efficiently. Lipid mixing was reported to occur as a result of fairly promiscuous endosomal *trans*-SNARE pairing ([@bib4]) and in multiple topologies ([@bib68]) without auxiliary proteins. However, another study ([@bib36]), which employed a content mixing assay to measure fusion, found that a Rab GTPase and its effectors are essential for endosomal SNARE-mediated fusion. Neuronal fusion has also been extensively studied through in vitro reconstitution, and led to the concept that SNAREs alone suffice as the machinery of fusion ([@bib21]). While SNAREs are undoubtedly essential components, their spontaneous assembly into a four-helical bundle only occurs very slowly ([@bib39]). Vital components that accelerate this assembly are more recently being included in the definition of a core machinery in this system. Rizo\'s group has provided compelling evidence for the critical roles of Munc18 and Munc13 during neuronal SNARE-mediated fusion, together with NSF/SNAP and the soluble domain of synaptotagmin 1 ([@bib28]), while Brunger\'s group has shown that complexin has a large effect on Ca^2+^ triggered synchronized fusion in the presence of neuronal SNAREs and full-length synaptotagmin 1 ([@bib8]; [@bib26]). Further study of these components can broaden our understanding of the complex mechanisms that regulate and facilitate membrane fusion.

Tethering may regulate vacuolar and other fusion systems. The highly selective distribution of each Rab GTPase, which serves as a receptor for its cognate tethering complex ([@bib19]), could impose specificity on otherwise promiscuous SNARE complex assembly ([@bib62]). Membrane repulsion and the conformation of unpaired, membrane-anchored SNAREs may limit the spontaneous formation of *trans*-SNARE complexes. Bringing membranes into close apposition and stabilizing such a tethered intermediate drastically enriches the local concentration of SNAREs and facilitates the interactions that promote *trans*-SNARE complex formation. Recent studies suggested that some multi-subunit tethering complexes could also directly modulate the assembly of functional SNARE complexes (reviewed in [@bib18]). Nevertheless, even in a tethered state, only a minor fraction (a few percent) of SNAREs seem to engage in such complexes ([@bib31]) and lowering the SNARE concentration only a few-fold can take a substantial toll on fusion activity ([@bib64]). Other factors that promote fusion, like Sec17p and Sec18p, further stimulate HOPS-dependent reactions ([Figure 1G](#fig1){ref-type="fig"}; [@bib31]; [@bib32]), but their mode of action is only poorly understood. The observation that Sec17p/Sec18p relieved the inhibition by soluble SNARE proteins ([Figure 6E](#fig6){ref-type="fig"} and [Figure 6---figure supplement 3B](#fig6s3){ref-type="fig"}) demonstrates the importance of dynamic cycling of SNARE interactions, and highlights the ability of HOPS to selectively protect productive *trans*-SNARE pairs ([@bib46]; [@bib17]; [@bib59]).

Tethering is integral to our working model of vacuolar homotypic fusion. ATP-dependent priming entails phosphoinositide synthesis ([@bib29]) and the disassembly of *cis*-SNARE complexes by Sec17p/Sec18p/ATP ([@bib16]; [@bib30]), providing SNAREs for later assembly of *trans*-SNARE complexes. HOPS mediates tethering ([@bib17]), possibly supported by the *trans*-interaction of the PX domain of Vam7p with PI(3)P ([@bib60]). Neuronal SNAREs can associate in multiple conformations ([@bib56]) that can participate in docking ([@bib3]). Similarly, the vacuolar SNAREs may associate in several conformations when pairing in *trans.* Additional factors that guide the formation of fusion-competent complexes, which might differ from fusion-incompetent complexes in composition, conformation, or associations, are required for rapid fusion. Our data indicate that tethering via HOPS or the binding of the Vam7p PX domain to PI(3)P in *trans* can provide such guidance. Earlier studies of intact vacuoles have also shown that the rate of fusion is not directly proportional to the level of *trans*-SNARE complexes ([@bib51]), suggesting that only a fraction of *trans*-SNARE interactions might also contribute to fusion activity in vivo.

In addition to its role in facilitating the formation of fusion-competent *trans*-SNARE complexes, tethering may play a direct role in lowering the energy barrier for fusion. Tethering could provide the activation energy required for partially assembled SNARE complexes to fully zipper ([@bib33]). It could also contribute by inducing membrane bending at the edges of tightly apposed membranes [(]{.ul}[@bib55][)]{.ul}. Domains like the vertex ring in vacuole fusion ([@bib55], [@bib54]; [@bib11]) require tethering complexes for their formation and stability. Fusogenic lipids, such as the non-bilayer lipids phosphatidylethanolamine, diacylglycerol, and sterol, are required for fusion ([@bib64]) and are dependent on other lipids and docking proteins for their enrichment at the vertex ring ([@bib11]). We propose that tethering may thus make several direct contributions to fusion, as well as its role in promoting *trans*-SNARE complexes in conjunction with additional auxiliary proteins.

Materials and methods {#s4}
=====================

Proteins and reagents {#s4-1}
---------------------

Lipids were obtained from Avanti Polar Lipids (Alabaster, AL), except for ergosterol which was from Sigma-Aldrich (St. Louis, MO), PI(3)P was from Echelon Biosciences (Salt Lake City, UT), and the fluorescent lipids (Marina-Blue-DHPE, NBD-DHPE, Rhodamine-DHPE, Oregon-Green-488-DHPE, Texas-Red-DHPE) were from Life Technologies (Carlsbad, CA). Biotinylated R-phycoerythrin was purchased from Life Technologies, Cy5-derivatized streptavidin from KPL (Gaithersburg, MD), and unlabeled streptavidin from Thermo Scientific (Waltham, MA). Sec18p ([@bib16]), Sec17p ([@bib43]), Ypt7p ([@bib65]), HOPS ([@bib65]), and vacuolar SNARE proteins ([@bib31]; [@bib43]; [@bib67]) were purified as described. Vti1p and Nyv1p were exchanged into octylglucoside buffer as described ([@bib67]). Soluble Nyv1p (sR) was purified as GST-TEVsite-Nyv1(Δtm) as described ([@bib50]), and cleaved with TEV protease prior to use. GST-His6-3Csite-Nyv1p was purified as described ([@bib20]).

Reconstitution of vacuolar Rab/SNARE proteoliposomes {#s4-2}
----------------------------------------------------

Proteoliposomes were prepared by detergent dialysis (20 kDa cutoff membrane) in RB150/Mg^2+^ (20 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 1 mM MgCl~2~, 10% glycerol \[vol/vol\]) as described ([@bib65]), with modifications. Lipids dissolved in chloroform were mixed at proportions that mimic the vacuolar lipid composition: 44.6--47.6 mol% POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), 18 mol% POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), 18 mol% Soy PI (L-α-phosphatidylinositol), 4.4 mol% POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine), 2 mol% POPA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate), 1 mol% 16:0 DAG (1,2-dipalmitoyl-sn-glycerol), 8 mol% ergosterol, and 1 mol% (unless specified otherwise) di-C16 PI(3)P (1,2-dipalmitoyl-*sn*-glycero-3-phospho-(1′-myo-inositol-3′-phosphate)). Different fluorescent lipids (Marina-Blue-DHPE, NBD-DHPE, rhodamine-DHPE, Oregon-Green-488-DHPE, Texas-Red-DHPE) were included to allow assays of lipid dequenching or lipid quenching. Concentrations are indicated in the figure legends of the respective experiments. Molar protein:lipid ratios were 1:1000 for SNAREs and 1:2000 for Ypt7p. Isolation after reconstitution was achieved by floatation on a three-step Histodenz gradient (35%, 25% Histodenz \[wt/vol\], and RB150/Mg^2+^); Histodenz (Sigma-Aldrich) solutions were prepared as 70% stock solution in modified RB150/Mg^2+^ with a reduced concentration (2% \[vol/vol\]) of glycerol to compensate for the osmotic activity of the density medium; lower concentration solutions were obtained by dilution with RB150/Mg^2+^. The proteoliposomes used in [Figures 6 and 7](#fig6 fig7){ref-type="fig"} were essentially prepared the same way, but with the dilinoleoyl-forms of PC, PE, PS, and PA, and with molar protein:lipid ratios for SNAREs as indicated.

RPL fusion assays {#s4-3}
-----------------

Fusion reactions of 20 µl were assembled from three pre-mixes: two mixes (5 µl each) of RPLs (250 µM lipid each) in RB150/Mg^2+^ with 5 µM streptavidin (for content mixing reactions only), and one mix of auxiliary factors (e.g., Sec17p, Sec18p, Mg^2+^:ATP, HOPS, anti-Vam3p, sNyv1p) or their respective buffers. All components were incubated individually at 27°C for 10 min, and then combined in wells of 384-well plates to initiate the reaction. The plates were incubated at 27°C in a fluorescence plate reader for 30--90 min and content and/or lipid mixing signals were recorded at intervals of 5--60 s in a SpectraMax Gemini XPS (Molecular Devices, Sunnyvale, CA) fluorescent plate reader (PhycoE:Cy5-FRET, Ex: 565 nm; Em: 670 nm; cutoff: 630 nm; Marina-Blue quenching or dequenching, Ex: 370 nm; Em: 465 nm; cutoff: 420 nm; NBD dequenching, Ex: 460 nm; Em: 538 nm; cutoff: 515 nm; Oregon-Green dequenching, Ex: 504 nm; Em: 534 nm; cutoff: 515 nm). For content mixing reactions, maximal values were determined after addition of 0.1% (wt/vol) Thesit to samples that had not received streptavidin. To estimate the extent of lipid mixing, liposomes mimicking 100% fusion were prepared by mixing respective 'donor' and 'acceptor' mixed micellar solutions 1:1 prior to liposome formation by dialysis.

Determination of *trans*-SNARE associations by co-immunoprecipitation {#s4-4}
---------------------------------------------------------------------

To estimate the amount of *trans*-SNARE association that formed during a reaction, the amount of Nyv1p that co-immunoprecipitated with Vam3p was determined. A 40 μl fusion reaction was incubated for 40 min at 27°C, placed on ice, and diluted 10-fold in RIPA buffer (20 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 0.2% \[wt/vol\] bovine serum albumin, 1% \[vol/vol\] Triton X-100, 1% \[wt/vol\] sodium cholate, 0.1% \[wt/vol\] sodium dodecyl sulfate) containing 50 μg/ml of affinity-purified anti-Vam3p antibody and 10 µM GST-Nyv1p. After 20 μl of RIPA-buffer washed protein A magnetic beads (Thermo Scientific, Portsmouth, NH) were added, the mix was incubated while nutating at room temperature for 2 hr. After the beads were washed three times with 1 ml of RIPA buffer, samples were eluted in 100 μl of reducing SDS sample buffer at 95°C for 5 min. Aliquots (20 μl) of each sample were subjected to SDS--PAGE and immunoblotting with anti-Nyv1p antibody.
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Thank you for sending your work entitled "A Distinct Tethering Step is Vital for Vacuole Membrane Fusion" for consideration at *eLife.* Your article was handled by Randy Schekman as Senior editor and generally favorably evaluated by 3 reviewers, one of whom is a member of our Board of Reviewing Editors. However, there are some significant concerns that require major revision as outlined below.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Axel Brunger (Reviewing editor); Jose Rizo (one of the peer reviewers).

It has been appreciated for some time now that lipid mixing may not necessarily imply content mixing. This work now adds even more rather unsettling evidence that lipid-dye dequenching assays should be treated with caution. The authors find that lipid-dye dequenching is asymmetric in their system, i.e., (de-) quenching occurs much more extensively when lipid dyes are included with one class of vesicles containing R-SNAREs than when they are included with vesicles containing Q-SNAREs. This asymmetry is not due merely to some unusual property of the particular type of fluorescence lipids chosen, since the authors show that analogous results were obtained with three different types of fluorescent lipids. Moreover, the data suggest that the observed dequenching of the lipid dyes is not due to complete fusion. A second key finding is that the tethering of HOPS on the vacuolar SNARE-bearing proteoliposomes initiates efficient lumenal compartment mixing. However, placing PI3P in the R-SNARE liposomes, vacuolar SNAREs alone can also induce efficient content mixing without HOPS.

Major comments:

1\) The results raise the question if it is lipid dye transfer that depends on the asymmetric vesicle composition? The authors rightfully say "We do not know how trans-SNARE interactions lead to this dequenching, but it is not symmetric, as expected for true lipid mixing, and is not proportionate to the content mixing for each reaction condition; thus, it cannot be relied on as a faithful reporter of fusion." What is the origin of the asymmetric lipid dye transfer? The authors should suggest a mechanism, especially since fusion inhibitors suppress the signal. In particular, could this be related to some sort of interaction between some of the vacuolar SNAREs, PI(3)P, and the dyes themselves? In other words, dye-lipids may be transferred to the other membrane that contains a particular SNARE via an interaction with that SNARE? In this context, transfer of lipid dyes between membranes has been previously observed (S. Ohki, T. D. Flanagan, and D. Hoekstra, Biochemistry, 1998, 37, 7496-503) for Rhodamine B lipids. Moreover, is it plausible that positively charged residues in the juxtamembrane regions of the Q SNAREs help to \'extract\' the fluorescent lipids from the R-liposomes when the two membranes are brought into proximity by the trans SNARE complexes, thus catalyzing transfer from the R- to the Q-liposomes? Another (albeit, less interesting) possibility that could explain their data is a different size distribution of vesicles and unequal dye partitioning. For example, if the R-SNARE vesicles are much smaller than the Q-SNARE vesicles, then the lipid dyes may partition non-randomly between leaflets in the R-SNARE vesicles but not in the Q-SNARE vesicles (e.g. one could have a much higher concentration of dyes in the outer leaflet of the R-SNARE vesicles than in the Q-SNARE vesicles). Then, upon hemifusion, there would be a greater fluorescence change if the dyes were in the R-SNARE vesicle originally than in the Q-SNARE vesicle. Small amounts of hemi-fusion would appear magnified in that case. Alternatively, there could be some interaction between the R-SNARE proteins and the lipid dye which make it undergo hemifusion more readily than if the dye is on the Q-SNARE vesicles.

2\) Relevant to point (1), the authors need to provide some characterization of their proteoliposomes, especially size distribution. This could be using dynamic light scattering or electron microscopy. Also, is there evidence that the protein and lipid dye incorporation is homogeneous?

3\) The content mixing assay also shows asymmetry ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}, and compare [Figure 1 D and 1G](#fig1){ref-type="fig"}, cases with HOPS and Sec18/HOPS). How can this be explained? Since an important aspect of this paper is the asymmetry observed in lipid mixing, it is important to establish whether the differences in the content mixing results constitute a true asymmetry or arise from differences in the amounts of probes trapped in the proteoliposomes in the different configurations. The authors should discuss this point and, ideally, should provide some characterization of the proteoliposomes to distinguish between these possibilities.

4\) The effect of asymmetric addition of PI(3)P on vacuolar SNARE-mediated content mixing is also interesting, but perhaps easier to explain. As suggested by the authors, this effect could be explained by a trans interaction between Vamp7p and PI(3)P. In the other vesicle, the effect is due to an increase in "tethering" by this trans interaction. However, upon inclusion of PI(3)P in both vesicle classes does not show such an increase. Could this be explained by "self-interactions" between Vamp7p and PI(3)P in its own membrane?

5\) Most of the data (except [Figure 5b](#fig5){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"}) only show one time point (fluorescence at ten minutes). Did the authors collect kinetic time traces, i.e. is the 10 min time point a reliable and representative measure in all cases? Or was no kinetic data collected? Because no kinetic data is shown for most figures, the differences in the data could be due to either different rates or different extents of fusion or both. In turn, that might suggest different underlying mechanisms. Showing the kinetic data, even if only in the supporting material, would be very useful. One of the principal advantages of doing bulk phase fusion experiments is that it is much easier and quicker to collect kinetic data, so why not exploit that?

6\) The second central claim of the paper is that the tethering action of HOPS is an essential upstream step to the fusion reaction. That may very well be true, but might not the data herein also support the idea that the action of HOPS is merely to stabilize the Q-SNAREs in a fusion-competent configuration such that they can mediate both tethering and fusion? Q-SNAREs in other systems are well known to form dead-end complexes that are not fusion competent (see, for example, reviews by Brunger, A.T. (2006) Quart. Rev. Biophys. 38,1-47. and Rizo, J., and Südhof, T.C. (2012). Annual Review of Cell and Developmental Biology 28, 279-308.). Might that be what is going on here? The authors suggest that only a fraction of their Q-SNARE vesicles seem to be fusion-competent ([Figure 2](#fig2){ref-type="fig"}, [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}, and in the text). Perhaps the essential role of HOPS in their experiments is not to tether the two membranes, but rather to stabilize Q-SNARE complexes in a fusion-competent configuration. Or perhaps both mechanisms of action are essential. The PI(3)P experiments in [Figure 5](#fig5){ref-type="fig"} partially address this question, but as the SNAREs are known to interact with PI(3)P, it may be that PI(3)P also stabilizes the fusion-competent configuration. Outside of single vesicle fusion experiments, which can easily visualize the tethering step, what is really needed is an experiment in which the vesicles are tethered in a manner independent of any of the fusion machinery. In a simplistic way, this could be done by using the same streptavidin tethering experiment as was used to collect the data in [Figure 6](#fig6){ref-type="fig"}, but using the yeast SNAREs and Ypt7p instead of the rat SNAREs (see note 7 below). Also, content mixing rather than lipid mixing should be used as a fusion readout in that experiment (see note 5).

7\) The data presented in [Figure 6](#fig6){ref-type="fig"} are used as evidence that tethering is also important for membrane fusion induced by endosomal SNAREs. However, all the data shown in the figure rely on a lipid-mixing assay. Hence, reliable conclusions from about membrane fusion cannot be drawn, given all problems inherent to interpret lipid mixing data. It is also unclear why the data are presented as rate of fluorescence decrease, in contrast to other figures of the paper. In addition, the data have large error bars and some reactions with an incomplete group of SNAREs (e.g. 1R 1R) yield a substantial effect that is about 30-40% of that obtained with 3Q and 1R. Therefore, these results are far from demonstrating that tethering is required for endosomal membrane fusion. The data could be omitted as they are not central to the key points of this paper, or a proper content mixing assay used, such as Tb3+-DPA or ANTS-DPX that should work nicely.

8\) Another concern with the streptavidin tethering experiments ([Figure 6](#fig6){ref-type="fig"}) is the physical role of streptavidin. In some ways, it might seem that tethering with streptavidin would inhibit fusion; many streptavidin molecules might attach themselves to the interface between the tethered vesicles, preventing trans-SNARE binding from that interface and only allowing the SNAREs to bind to each other at the periphery of the contact area. In effect, they might clog up the interface. Is streptavidin added at a low enough concentration that this can be ruled out? What do the authors think is going on here?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for sending your work entitled "A Distinct Tethering Step is Vital for Vacuole Membrane Fusion" for consideration at *eLife.* Your article has been favorably evaluated by Randy Schekman (Senior editor) and 3 reviewers, one of whom is a member of our Board of Reviewing Editors. However, there are some remaining issues that need to be addressed.

The following individuals responsible for the peer review of your submission have agreed to reveal their identity: Axel Brunger (Reviewing editor); Stephen Boxer and Joseph Rizo (peer reviewers).

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

We would like to thank the authors for addressing the concerns that were raised in the previous reviews. The new results presented in [Figure 6](#fig6){ref-type="fig"} are indeed very interesting and add to this paper.

Comments:

1\) The authors should stress in various places (Abstract, Introduction, and Discussion) that the findings of asymmetric lipid mixing add another problem for lipid mixing assays. Thus, they should not be just "employed with caution" (as stated in the Discussion), but with "great caution", and should always be accompanied by a complete sets of content mixing experiments (not just one as I have seen in some papers).

2\) The authors\' interpretation of the new data in [Figure 6](#fig6){ref-type="fig"} (that the role of HOPS in fusion is not just its tethering action), seems to be at odds with the data in [Figure 5](#fig5){ref-type="fig"}. In [Figure 5A](#fig5){ref-type="fig"}, when PI3P is only on the R SNARE vesicles (mimicking the tethering action of HOPS), then similar levels of fusion are observed with and without HOPS. Doesn\'t this suggest that the central role of HOPS is only to tether the vesicles together? If HOPS is also involved in stabilizing a fusion competent conformation of snare proteins or influencing fusion through some other action, then shouldn\'t there be an increase in fusion when HOPS is added? The authors should reconcile their interpretation of the data with this point.

3\) The authors state that the lipid dequenching signal showed an asymmetric character "suggesting that it arises without the mixing of two bilayers." We recommend that the authors remove that clause as it seems to suggest a rather unphysical interpretation of the data. The discussion following that statement is sufficient to convey their main point that lipid mixing only experiments should be used with caution.

4\) It is good that the authors have included example kinetic traces in the supplementary material. However, upon the inspection of that data, it seems as though the 10 minute time point (which is what is used for the bulk of the data in the main manuscript) is not always a faithful reporter of either the extent or the rate of the fusion reaction. For example, compare the Sec17/Sec18/HOPS trace (purple) to the no addition trace (blue) in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"} at t=10 vs. at t=30 min. Why not show the kinetic traces in the main text or represent it in another way?

5\) The authors argue that trans-SNARE complexes alone are not sufficient for fusion because some trans SNARE complexes were formed in the absence of HOPS and HOPS increases the amount of trans SNARE complexes three-fold while stimulating fusion 100-fold. Although I think that the authors are most likely right, the results could also be explained if there is high cooperativity in the system so that below a certain threshold in the number of SNARE complexes there is no or little fusion, and fusion becomes much more efficient above this threshold. Perhaps the authors would like to include this in the Discussion.

6\) From an editorial perspective, the authors are asked to consider moving most supplemental figures into the main text (except those that are purely "data" figures). The scattering of figures between main figures and supplemental figures makes it more difficult to read the paper. One of the important features of *eLife* is that it does not have a limit on the number of figures, which sets it apart from most other journals. Also, subtitles in the Results section would be desirable to separate some of the key findings.

10.7554/eLife.03251.023

Author response

*1) The results raise the question if it is lipid dye transfer that depends on the asymmetric vesicle composition? The authors rightfully say "We do not know how trans-SNARE interactions lead to this dequenching, but it is not symmetric, as expected for true lipid mixing, and is not proportionate to the content mixing for each reaction condition; thus, it cannot be relied on as a faithful reporter of fusion.". What is the origin of the asymmetric lipid dye transfer? The authors should suggest a mechanism, especially since fusion inhibitors suppress the signal. In particular, could this be related to some sort of interaction between some of the vacuolar SNAREs, PI(3)P, and the dyes themselves? In other words, dye-lipids may be transferred to the other membrane that contains a particular SNARE via an interaction with that SNARE? In this context, transfer of lipid dyes between membranes has been previously observed (S. Ohki, T. D. Flanagan, and D. Hoekstra, Biochemistry, 1998, 37, 7496-503) for Rhodamine B lipids. Moreover, is it plausible that positively charged residues in the juxtamembrane regions of the Q SNAREs help to \'extract\' the fluorescent lipids from the R-liposomes when the two membranes are brought into proximity by the trans SNARE complexes, thus catalyzing transfer from the R- to the Q-liposomes? Another (albeit, less interesting) possibility that could explain their data is a different size distribution of vesicles and unequal dye partitioning. For example, if the R-SNARE vesicles are much smaller than the Q-SNARE vesicles, then the lipid dyes may partition non-randomly between leaflets in the R-SNARE vesicles but not in the Q-SNARE vesicles (e.g. one could have a much higher concentration of dyes in the outer leaflet of the R-SNARE vesicles than in the Q-SNARE vesicles). Then, upon hemifusion, there would be a greater fluorescence change if the dyes were in the R-SNARE vesicle originally than in the Q-SNARE vesicle. Small amounts of hemi-fusion would appear magnified in that case. Alternatively, there could be some interaction between the R-SNARE proteins and the lipid dye which make it undergo hemifusion more readily than if the dye is on the Q-SNARE vesicles*.

As mentioned under point 2, new data on the characterization of the RPLs has been added. But this data does not support a simple resolution to the mystery as proposed in the 2^nd^ half of this comment. The phenomenon of asymmetry is important in that it uncovered that lipid mixing assays cannot be relied on comfortably. What precise mechanism underlies the observed asymmetry is unclear. We have added a section to the text discussing several possibilities based exactly on the points raised above without drifting too far into speculations.

2\) Relevant to point (1), the authors need to provide some characterization of their proteoliposomes, especially size distribution. This could be using dynamic light scattering or electron microscopy. Also, is there evidence that the protein and lipid dye incorporation is homogeneous?

We have added data as [Figure 3--figure supplements 2 and 3](#fig3s2 fig3s3){ref-type="fig"} (DLS size measurements, stained gel, characterization of dye incorporation) to address these points.

*3) The content mixing assay also shows asymmetry (*[*Figure 1--supplement 1*](#fig1s1){ref-type="fig"}*, and compare* [*Figure 1 D and 1G*](#fig1){ref-type="fig"}*, cases with HOPS and Sec18/HOPS). How can this be explained? Since an important aspect of this paper is the asymmetry observed in lipid mixing, it is important to establish whether the differences in the content mixing results constitute a true asymmetry or arise from differences in the amounts of probes trapped in the proteoliposomes in the different configurations. The authors should discuss this point and, ideally, should provide some characterization of the proteoliposomes to distinguish between these possibilities*.

Under standard reaction conditions no asymmetry was observed for content mixing assays. The differences when comparing [Figures 1D and 1G](#fig1){ref-type="fig"} arise from the fact that 1D is a 4SNARE-4SNARE reaction, thus depending on Sec17/Sec18 activity to disassemble cis-SNARE complexes, while 1G represents a 1R-3Q reaction, which does not depend on the concerted action of Sec17 and Sec18. The differences that were observed in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"} are only seen when the ratio of the two RPL populations is altered. There is no apparent difference when comparing the 1:1 conditions. The differences that can be observed when the ratios are shifted are more likely due to the fact that an imbalance between 1R and 3Q RPLs is created in favor of one or the other. This and other experiments suggest that not all 3Q-RPLs are readily fusion competent. We have modified the text to provide more clarity about these points.

*4) The effect of asymmetric addition of PI(3)P on vacuolar SNARE-mediated content mixing is also interesting, but perhaps easier to explain. As suggested by the authors, this effect could be explained by a trans interaction between Vamp7p and PI(3)P. In the other vesicle, the effect is due to an increase in "tethering" by this trans interaction. However, upon inclusion of PI(3)P in both vesicle classes does not show such an increase. Could this be explained by "self-interactions" between Vamp7p and PI(3)P in its own membrane*?

Precisely this is what we assume to be the case. We have modified the text to make this clear.

*5) Most of the data (except* [*Figure 5b*](#fig5){ref-type="fig"} *and* [*Figure 6*](#fig6){ref-type="fig"}*) only show one time point (fluorescence at ten minutes). Did the authors collect kinetic time traces, i.e. is the 10 min time point a reliable and representative measure in all cases? Or was no kinetic data collected? Because no kinetic data is shown for most figures, the differences in the data could be due to either different rates or different extents of fusion or both. In turn, that might suggest different underlying mechanisms. Showing the kinetic data, even if only in the supporting material, would be very useful. One of the principal advantages of doing bulk phase fusion experiments is that it is much easier and quicker to collect kinetic data, so why not exploit that*?

Data has been collected as kinetic time traces. We have now included representative kinetic data as figure supplements for all figures.

*6) The second central claim of the paper is that the tethering action of HOPS is an essential upstream step to the fusion reaction. That may very well be true, but might not the data herein also support the idea that the action of HOPS is merely to stabilize the Q-SNAREs in a fusion-competent configuration such that they can mediate both tethering and fusion? Q-SNAREs in other systems are well known to form dead-end complexes that are not fusion competent (see, for example, reviews by Brunger, A.T. (2006) Quart. Rev. Biophys. 38,1-47. and Rizo, J., and Südhof, T.C. (2012). Annual Review of Cell and Developmental Biology 28, 279-308.)*. *Might that be what is going on here? The authors suggest that only a fraction of their Q-SNARE vesicles seem to be fusion-competent (*[*Figure 2*](#fig2){ref-type="fig"}*,* [*Figure 5--figure supplement 1*](#fig5s1){ref-type="fig"}*, and in the text). Perhaps the essential role of HOPS in their experiments is not to tether the two membranes, but rather to stabilize Q-SNARE complexes in a fusion-competent configuration. Or perhaps both mechanisms of action are essential. The PI(3)P experiments in* [*Figure 5*](#fig5){ref-type="fig"} *partially address this question, but as the SNAREs are known to interact with PI(3)P, it may be that PI(3)P also stabilizes the fusion-competent configuration. Outside of single vesicle fusion experiments, which can easily visualize the tethering step, what is really needed is an experiment in which the vesicles are tethered in a manner independent of any of the fusion machinery. In a simplistic way, this could be done by using the same streptavidin tethering experiment as was used to collect the data in* [*Figure 6*](#fig6){ref-type="fig"}*, but using the yeast SNAREs and Ypt7p instead of the rat SNAREs (see note 7 below). Also, content mixing rather than lipid mixing should be used as a fusion readout in that experiment (see note 5).*

The HOPS complex is certainly more than a simple tether, and it remains to be sorted out in detail what "the tethering action of HOPS" involves. Experiments with streptavidin as an artificial tether had been performed in the past (see [@bib65]; [Figure 6A](#fig6){ref-type="fig"} -- this is lipid mixing data, since our content mixing data also utilizes streptavidin:biotin binding, and small molecule content mixing assays like Tb3+-DPA or ANTS-DPX are impractical due to membrane permeation in our system (see [@bib67])), suggesting that one of the functions is indeed to bring the membranes into close apposition.

We have added new data (new [Figure 6](#fig6){ref-type="fig"}), which shows that the 3Q-RPLs readily engage soluble R-SNARE, showing that the partial 3Q complex retains competence for interaction with the R-SNARE. This data also shows that membrane anchored SNAREs engage in trans-associations with little ensuing fusion activity. Adding HOPS increases the amount of trans-SNARE interaction only a few fold, while it increases the rate of fusion much more dramatically (\> 100-fold). This suggests that trans-SNARE interactions can be of different qualities, some fusion-competent, some not. Future work will have to delineate the multiple functions of HOPS, and will also provide further insight into what defines a tethering event. We have expanded our discussion of this in the manuscript in conjunction with the newly added data, to address directly the question of whether the 3Q-complex is active and whether or not HOPS might primarily act by stabilizing it, as you suggested.

*7) The data presented in* [*Figure 6*](#fig6){ref-type="fig"} *are used as evidence that tethering is also important for membrane fusion induced by endosomal SNAREs. However, all the data shown in the figure rely on a lipid-mixing assay. Hence, reliable conclusions from about membrane fusion cannot be drawn, given all problems inherent to interpret lipid mixing data. It is also unclear why the data are presented as rate of fluorescence decrease, in contrast to other figures of the paper. In addition, the data have large error bars and some reactions with an incomplete group of SNAREs (e.g. 1R 1R) yield a substantial effect that is about 30-40% of that obtained with 3Q and 1R. Therefore, these results are far from demonstrating that tethering is required for endosomal membrane fusion. The data could be omitted as they are not central to the key points of this paper, or a proper content mixing assay used, such as Tb3+-DPA or ANTS-DPX that should work nicely*.

Old [Figure 6](#fig6){ref-type="fig"} has been removed.

*8) Another concern with the streptavidin tethering experiments (*[*Figure 6*](#fig6){ref-type="fig"}*) is the physical role of streptavidin. In some ways, it might seem that tethering with streptavidin would inhibit fusion; many streptavidin molecules might attach themselves to the interface between the tethered vesicles, preventing trans-SNARE binding from that interface and only allowing the SNAREs to bind to each other at the periphery of the contact area. In effect, they might clog up the interface. Is streptavidin added at a low enough concentration that this can be ruled out? What do the authors think is going on here*?

Old [Figure 6](#fig6){ref-type="fig"} has been removed.

*\[Editors\' note: further revisions were requested prior to acceptance, as described below*.*\]*

*1) The authors should stress in various places (Abstract, Introduction, and Discussion) that the findings of asymmetric lipid mixing add another problem for lipid mixing assays. Thus, they should not be just "employed with caution" (as stated in the Discussion), but with "great caution", and should always be accompanied by a complete sets of content mixing experiments (not just one as I have seen in some papers)*.

We have modified the text to express more clearly that content mixing assays are the current 'gold standard' for membrane fusion studies, as several lines of evidence show that conclusions drawn solely from data obtain through lipid mixing assays are not sufficiently reliable.

*2) The authors\' interpretation of the new data in* [*Figure 6*](#fig6){ref-type="fig"} *(that the role of HOPS in fusion is not just its tethering action), seems to be at odds with the data in* [*Figure 5*](#fig5){ref-type="fig"}*. In* [*Figure 5A*](#fig5){ref-type="fig"}*, when PI3P is only on the R SNARE vesicles (mimicking the tethering action of HOPS), then similar levels of fusion are observed with and without HOPS. Doesn\'t this suggest that the central role of HOPS is only to tether the vesicles together? If HOPS is also involved in stabilizing a fusion competent conformation of snare proteins or influencing fusion through some other action, then shouldn\'t there be an increase in fusion when HOPS is added? The authors should reconcile their interpretation of the data with this point*.

The data in [Figure 6](#fig6){ref-type="fig"} suggests that *trans*-SNARE complexes exist in at least two states, fusion-competent and fusion- incompetent. Future studies will need to determine in what aspects these complexes differ, and what favors the formation of one over the other. At this point, it is not clear what HOPS contributes beyond tethering. Tethering via HOPS might provide a certain spatial arrangement favoring the formation of fusion-competent complexes. The binding of PX:PI3P in *trans* may provide such favorable conditions by other means. We do not necessarily see a contradiction in this. But it is certainly clear that additional work is required to understand the mechanistic details of all events upstream of a fully zippered trans-SNARE complex. We took your comment as a stimulus to expand this portion in the Discussion section.

*3) The authors state that the lipid dequenching signal showed an asymmetric character "suggesting that it arises without the mixing of two bilayers." We recommend that the authors remove that clause as it seems to suggest a rather unphysical interpretation of the data. The discussion following that statement is sufficient to convey their main point that lipid mixing only experiments should be used with caution*.

Removed.

*4) It is good that the authors have included example kinetic traces in the supplementary material. However, upon the inspection of that data, it seems as though the 10 minute time point (which is what is used for the bulk of the data in the main manuscript) is not always a faithful reporter of either the extent or the rate of the fusion reaction. For example, compare the Sec17/Sec18/HOPS trace (purple) to the no addition trace (blue) in* [*Figure 5*--*figure supplement 1*](#fig5s1){ref-type="fig"} *at t=10 vs. at t=30 min. Why not show the kinetic traces in the main text or represent it in another way*?

We have consciously chosen to present the 10 minute time point, rather than the full kinetic traces, in the main manuscript. It aids the comparison of different conditions (making it more easily accessible to a broader readership) and provides an adequate measure in almost all cases. The kinetic traces are provided for expert readers, and we now explicitly point out the two conditions which exhibit a distinct pattern (i.e., conditions with Sec17/Sec18 and HOPS with no PI3P on the 3Q-RPLs -- conditions under which there is no apparent synergy between Sec17/Sec18 and HOPS).

*5) The authors argue that trans-SNARE complexes alone are not sufficient for fusion because some trans SNARE complexes were formed in the absence of HOPS and HOPS increases the amount of trans SNARE complexes three-fold while stimulating fusion 100-fold. Although I think that the authors are most likely right, the results could also be explained if there is high cooperativity in the system so that below a certain threshold in the number of SNARE complexes there is no or little fusion, and fusion becomes much more efficient above this threshold. Perhaps the authors would like to include this in the Discussion*.

We have experimentally addressed the possibility of high cooperativity as a reason for our observations, and present data that rules out this possibility in new [Figure 7](#fig7){ref-type="fig"}. In short, lowering the protein:lipid ratio on R-RPLs (while keeping it constant on the 3Q-RPLs) does not substantially affect the amount of fusion observed in the presence of HOPS, while the amount of *trans*-SNARE interactions decreases. The amount of *trans*-interaction at a protein:lipid ratio of 1:16000 on R- RPLs in the presence of HOPS is lower than at a protein:lipid ratio of 1:2000 on R-RPLs in the absence of HOPS, yet the maximal rate of fusion observed under these two conditions is vastly higher for R-RPLs at 1:16000 with HOPS than for R-RPLs at 1:2000 without HOPS (compare [Figure 7](#fig7){ref-type="fig"}, panels C&D, columns 2&7).

*6) From an editorial perspective, the authors are asked to consider moving most supplemental figures into the main text (except those that are purely "data" figures). The scattering of figures between main figures and supplemental figures makes it more difficult to read the paper. One of the important features of eLife is that it does not have a limit on the number of figures which sets it apart from most other journals. Also, subtitles in the Results section would be desirable to separate some of the key findings*.

We have carefully considered both requests. Subtitles were added to the Results section. Regarding the Supplementary material, we have chosen to leave the arrangement as it was. We agree that supplementary figures sometimes disrupt the flow of reading a paper, but also feel that the same happens when there are too many "primary" figures. In our opinion, *eLife* has an elegant solution by showing additional data as Figure supplements rather than Supplementary figures. What initially might appear to be a matter of semantics, is in fact an elegant twist that becomes apparent when reading the online version of an *eLife* paper. All Figure supplements are readily accessible right next to the corresponding primary figure. We find that this is indeed the best solution, and hope that you agree.
